in-PharmaTechnologist.com presents its round-up of the latest pharmaceutical industry appointments, including news from Okairos, Immunovaccine, and SteadyMed.
SGS Life Sciences has added cell-based bioassays to the range of services available at its Poitiers, France, facility in what it says is part of its new aggressive growth strategy.
AmerisourceBergen has bought informatics firm IntrinsiQ for $35m (€25m) continuing the spending spree it began earlier this week with the acquisition of market access consultancy Premier Source.
Cetero has strengthened its infrastructure with expansions in multiple clinical dermatology and transdermal delivery system (TDDS) services at four of its facilities.
Outsourcing-Pharma presents its round up of the latest appointments within the pharmaceutical industry, with news from Nycomed, Numira, Isotechnika, and Corcept.
in-Pharma Technologist brings you its round-up of the new appointments within the pharmaceutical industry, including news from Merck KGaA, Sanofi Pasteur, H&P and CADTH.
inVentiv Health says European communications group’s new ‘super agency’ structure will help it to compete in a market dominated by large multi-nationals.
Drug counterfeiters are using the Caribbean as a transport hub to ship fake pharmaceutical around the world according to the Antigua Pharmaceutical Society.
The number of in-transit pharmaceutical robberies in the US has been sliced by almost half since last year, according to FreightWatch’s Biannual Cargo Theft Report.
The pharma biobanking and compound management services sector welcomed its newest member last week with Brooks Automation’s acquisition of Nexus Biosystems.
US drugmaker Merck & Co announced plans to reduce its workforce by 13 percent, or 13,000 employees, in a bid to cut costs and focus its efforts in emerging markets.
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, GlaxoSmithKline, Croda and Provectus.
Express Script will take over fellow PBM Medco after a definitive merger agreement was unanimously approved by the boards of directors of both companies.
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, will news from Paragon, Pantheon, Amgen and PharmaNet.
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, which news from Aesica, SCM, Phlexglobal and Celerion.
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Merck Serono, Ascletis, Allon, Acura, Sangamo and ProStrakan.
Onco Therapies Limited (OTL), a division of Aglia, a wholly owned subsidiary of Strides Arcolab Limited, has been given the go ahead from Europe for its Oral Dosage Oncology facility.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
Sherpa Clinical Packaging says its new facility has passed an inspection by the California Food and Drug Branch (FDB) of the Department of Public Health.
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
Firecrest Clinical has launched a mobile version of its site management and training platform, citing investigator demand for trial in your hand solutions and sponsor demand for increased research efficiency.
Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
